Indivior Share Discussion Threads

[steeplejack] 29/3/2023 12:58

Thereagain,GW Phamaceuticals abandoned AIM a few years back and listed on Nasdaq and was then taken over by Jazz Pharmaceuticals in 2021.Since MIFID2,research coverage for small,mediumUK companies (on the AIM market in particular) has diminished.Indivior is a FT250 constituent but it could well attract better research coverage in the USA and there are currency considerations.US funds might well be reticent to purchase sterling denominated stocks or pay UK government stamp duty for that matter.In any event,Indivior’;s main market is the US and anything which makes the stock more accessible to US investors is eminently sensible.Nowadays,global markets would suggest that things on different exchanges get pretty much equalised but there are clear investor relations advantages in being a quoted vehicle in your primary market.As for the good old UK LSE,the daily traded turnover in heavyweights like Amazon and Apple regularly exceeds the total daily turnover on the UK market.

[dealy] 29/3/2023 08:43

just taken up my fist position in this for 2 years.

[dealy] 27/3/2023 14:24

I have given up using reasoning

[tommibone] 27/3/2023 12:03

But the opioid crisis in the US is where most of the treatment is delivered. Surely the relevance of the market will aid to this?

[dealy] 25/3/2023 17:28

The AIM / UK Ad Tech company Tremor made a big song and dance about how an additional Nasdaq listing would boost its valuation. Since then its shares are down 75%. Clearly it had no positive effect. In general US listings of small / mid caps do not offer higher valuations than the uk. The hurdles and headwinds are the same

[casholaa] 23/3/2023 13:03

Get yourself back up there, give us some g-force toward the sky!

[casholaa] 22/3/2023 10:45

They stated dual-listing will be in the Spring.

[casholaa] 21/3/2023 14:52

Spring started yesterday and runs to 21 June. Also, I think it's about to start gaining ground again but the 'market' rarely agrees with me so dyor + gla

[steeplejack] 06/3/2023 23:38

The UK equity market(as pointed out by numerous broad sheet articles of late)is becoming a secondary market in a global context.The FTSE 100 is comprised of a multiplicity of stocks that trade more extensively in the US than London.What with the march of private equity,the increasing competition of overseas stockmarkets and the inability to attract new listings let alone retain the existing ones,the LSE is under real pressure.Brexit hasn't helped the cause.Indivior is one of many who have taken the opportunity to seek a wider investment audience in the USA.Indivior could be a highly prized takeover candidate.The fly in the ointment is the litigation issue of course.Not insurmountable perhaps.

[ricky46] 06/3/2023 16:09

The Nasdaq listing will

[dealy] 06/3/2023 10:50

not sure what is going to get this moving up again

[florenceorbis] 05/3/2023 09:17

Support maintained at 1504p

[misca2] 27/2/2023 08:47

Support still maintained at 1510p

[glasgow13] 27/2/2023 08:45

sarkasm thanks

[glasgow13] 27/2/2023 08:36

How long has the buy back got to go?

[waldron] 22/2/2023 21:48

1510.00 GBX

[casholaa] 22/2/2023 21:46

I'd say well below 1500p, even if it takes a breather

[grupo guitarlumber] 21/2/2023 09:43

Strong support at 1544p

[steeplejack] 21/2/2023 09:33

Looks like the market is toying with the idea of putting the stock back into a trading range of £14-£16 that persisted for 6 months between April 22 to Oct 22.

[littleton2] 18/2/2023 08:47

Starting to look good.

[redbaron10] 17/2/2023 09:50

Sold out here six months ago but back in now.Results were really positive despite the millions put aside for liabilities.There is always an element of worst case scenario with many of these legal cases but ever since this was hived off from Reckitt there's been this cloud.If you accept the risk this has big potential going forward imho.Addictions and their sufferers will always need help sadly.